🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase IIa, randomised, double-blind, placebo-controlled, multiple...
Status
Completed
Location
Baptist Health Certer for Clinical Research
Start Date
2013-05
Trial ID
NCT01855880
This study is to establish the safety, determine if there is an improvement...
Status
Terminated
Location
Stanford University, School of Medicine
Start Date
2015-05
Trial ID
NCT02436460
Treatments Being Tested
This is a single-center Phase I study to determine the maximum tolerated do...
Status
Completed
Location
Froedtert Hospital and the Medical College of Wisconsin
Start Date
2020-12-14
Trial ID
NCT04144036
Treatments Being Tested
This is a phase II, randomised, double-blind, placebo-controlled, multiple-...
Status
Completed
Location
Alliance Dermatology & MOHS Center, PC
Start Date
2014-05
Trial ID
NCT02223039
The aim of the study is to investigate safety, tolerability and pharmacokin...
Status
Completed
Location
1304.1.4901 Boehringer Ingelheim Investigational Site
Start Date
2011-06
Trial ID
NCT01378364
This study is to assess the efficacy of Neihulizumab versus "conventional t...
Status
Withdrawn
Location
MD Anderson Cancer Center
Start Date
2016-07
Trial ID
NCT02694770
Treatments Being Tested
To evaluate efficacy, safety, tolerability, and immunogenicity of AbGn-168H...
Status
Completed
Location
UC San Diego
Start Date
2015-01
Trial ID
NCT02267642
Treatments Being Tested
The general aim of the trial is to determine the safety, tolerability and p...
Status
Completed
Location
1240.1.05 Boehringer Ingelheim Investigational Site
Start Date
2008-12
Trial ID
NCT00848055